BioCorRx Inc. (BICX) Financial Statements (2024 and earlier)

Company Profile

Business Address 2390 EAST ORANGEWOOD AVENUE
ANAHEIM, CA 92806
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 8093 - Specialty Outpatient Facilities, Not Elsewhere Classified (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1972046939111213
Cash and cash equivalents1972046939111213
Receivables      
Prepaid expense1275783103126155
Other undisclosed current assets10584166190130220
Total current assets:430344317333368587
Noncurrent Assets
Operating lease, right-of-use asset209240270300329357
Property, plant and equipment647077839096
Long-term investments and receivables 454545454545
Long-term investments 454545454545
Intangible assets, net (including goodwill)  10  11
Intangible assets, net (excluding goodwill)  10  11
Deferred costs   48484848
Other undisclosed noncurrent assets1010 1111 
Total noncurrent assets:327365450486522557
TOTAL ASSETS:7577097678198901,145
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:4,2974,1523,9083,4223,6003,227
Interest and dividends payable1,166
Accounts payable2,2562,1902,0131,2671,151896
Accrued liabilities1,2331,2201,207   
Other undisclosed accounts payable and accrued liabilities8087426882,1552,4491,166
Deferred revenue162533353535
Debt360350298221221221
Due to related parties1,188991685  
Other undisclosed current liabilities1,031138134131939929
Total current liabilities:5,7035,8535,3644,4944,7964,413
Noncurrent Liabilities
Long-term debt and lease obligation   74217250283
Long-term debt, excluding current maturities   74   
Liabilities, other than long-term debt1121,337185112029
Deferred revenue444112029
Due to related parties1,188    
Operating lease, liability108145181217250283
Other undisclosed noncurrent liabilities3,6522,3463,3453,2983,2863,174
Total noncurrent liabilities:3,7653,6833,6053,5253,5563,486
Total liabilities:9,4679,5368,9688,0208,3527,898
Equity
Equity, attributable to parent, including:(8,583)(8,701)(8,202)(7,078)(7,341)(6,635)
Common stock988877
Common stock, share subscribed but unissued, subscriptions receivable  (300)    
Common stock, value, subscriptions100100100100100100
Additional paid in capital67,55566,81566,13065,96964,75764,147
Accumulated deficit(76,268)(75,346)(74,336)(73,176)(72,227)(70,911)
Other undisclosed equity, attributable to parent2222(104)222222
Equity, attributable to noncontrolling interest(127)(126) (122)(120)(118)
Total equity:(8,711)(8,827)(8,202)(7,200)(7,462)(6,754)
TOTAL LIABILITIES AND EQUITY:7577097678198901,145

Income Statement (P&L) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues204083941621
Cost of revenue(10)(9)(12)(2)(3)(2)
Gross profit:93271921319
Operating expenses(967)(1,097)(1,269)(1,124)(1,374)(1,145)
Other undisclosed operating income10912232
Operating loss:(947)(1,056)(1,186)(1,029)(1,358)(1,125)
Nonoperating income2346237841180
Other nonoperating income    139  
Interest and debt expense(34)(26)332(199)(100)(167)
Loss from continuing operations before equity method investments, income taxes:(958)(1,037)(831)(1,150)(1,418)(1,112)
Other undisclosed income (loss) from continuing operations before income taxes  (133)   
Loss from continuing operations:(958)(1,037)(964)(1,150)(1,418)(1,112)
Loss before gain (loss) on sale of properties:(1,150)(1,418)(1,112)
Other undisclosed net income  2,0478,555  2,057
Net income (loss):(958)1,0117,591(1,150)(1,418)945
Other undisclosed net income (loss) attributable to parent 34(2,021)(8,754)199100(1,890)
Net loss available to common stockholders, diluted:(924)(1,011)(1,163)(951)(1,318)(945)

Comprehensive Income ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net income (loss):(958)1,0117,591(1,150)(1,418)945
Comprehensive income (loss), net of tax, attributable to parent:(958)1,0117,591(1,150)(1,418)945

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: